The inhibition of the dihydroorotate dehydrogenase (DHODH), an enzyme in the de novo pyrimidine synthesis pathway, blocks cancer cell proliferation through induction of replication and nucleolar stress, activation of p53, and the ATR/CHK1 pathway [94]. The gene discussed is DHODH; the disease is cancer.